Psilocybin Legal States 2026: The Complete Map
As of April 2026, three states have operational legal psilocybin frameworks for adults, two more have passed legislation and are building their programs, and over a dozen have active decriminalization measures or pending legislation. The landscape is moving faster than most observers predicted five years ago — and slower than advocates hoped.
This article covers every state with meaningful legal change, what each law actually allows, and what to realistically expect for access in 2026.
States with Legal Access (Operating Programs)
Oregon
Status: Legal, operating since January 2023 What's legal: Supervised psilocybin sessions at licensed service centers for adults 21+. No medical diagnosis required. No residency requirement. What's not legal: Personal possession, home cultivation, or use outside a licensed facility. Program details: Regulated by the Oregon Health Authority (OHA). Licensed facilitators and licensed service centers are searchable in the OHA registry. The program had a difficult first two years — high startup costs and compliance requirements pushed approximately a third of early service centers to close by mid-2024 — but has stabilized into a smaller, more sustainable core of operating facilities by 2026. Cost: $800–$3,500+ for a full session package. No insurance coverage. Access in 2026: Operational. Portland, Eugene, Ashland, and Bend have the most service centers. Book 4–8 weeks in advance for popular centers.
Colorado
Status: Legal, operating since 2024 What's legal: (1) Licensed healing centers for supervised sessions, adults 21+, no diagnosis required, no residency requirement. (2) Personal adult use — adults 21+ may possess, cultivate, and gift psilocybin mushrooms privately. What's not legal: Commercial sale outside licensed system. Public use. Providing to anyone under 21. Program details: Regulated by the Department of Regulatory Agencies (DORA). Colorado's framework differs from Oregon's in two important ways: licensed mental health professionals can serve as facilitators (enabling integration with clinical psychotherapy), and adults can legally cultivate and use mushrooms at home without going through a licensed facility at all. Cost: $1,000–$4,000+ for licensed healing center sessions. Personal cultivation costs only supplies. Access in 2026: Operational. Denver and Boulder have the highest concentration of healing centers. Home cultivation legal for residents.
New Mexico
Status: Legal, licensing underway — first facilities expected late 2026 What's legal: The Psilocybin Services Act was signed into law in 2026, establishing a licensed psilocybin services framework modeled on Oregon and Colorado. The program is in its regulatory buildout phase. What's not legal: Personal possession and cultivation remain illegal under New Mexico state law. The law creates a licensed facility pathway only. Timeline: New Mexico's Department of Health is working through rulemaking. License applications for facilitators and service centers are expected to open in mid-to-late 2026. First legal sessions are anticipated in late 2026 or early 2027. Access in 2026: Not yet operational. Watch the New Mexico Department of Health for licensing announcements. Albuquerque and Santa Fe are expected to be primary markets.
States with Decriminalization (Not Legal Programs)
Decriminalization means personal possession and use of psilocybin has been deprioritized for law enforcement — it is not legal, but enforcement is lowest priority and personal use typically carries no criminal penalty. Decriminalization does not create any pathway to purchase or obtain psilocybin legally.
California
Statewide decriminalization: SB 519, which would have legalized psilocybin statewide, was vetoed by Governor Newsom in 2023. However, several California cities have decriminalized:
- Oakland — decriminalized all plant medicines and fungi including psilocybin in 2019 (first major city to do so)
- Santa Cruz — decriminalized in 2020
- San Francisco — city decriminalization effective 2022
- Los Angeles — decriminalized in 2023
A new California ballot initiative for 2026 is gathering signatures but has not qualified as of April 2026. Statewide decriminalization through the legislature remains likely in the near term; full licensed program on Oregon/Colorado model would require a ballot measure or further legislation.
Washington, D.C.
Initiative 81, passed by 76% of voters in 2020, made personal possession and cultivation of psilocybin and other plant medicines the lowest law enforcement priority. This is broad de facto decriminalization. However, D.C. operates under congressional oversight, and no licensed program framework has been established. Personal use faces minimal enforcement risk.
Massachusetts
Cambridge, Somerville, Northampton, and Easthampton have enacted city-level decriminalization. A statewide ballot initiative for 2026 — the Natural Psychedelic Substances Act — qualified for the November 2026 ballot and would create a licensed psilocybin services framework similar to Oregon's if passed. This is the most significant pending vote of 2026.
Michigan
Ann Arbor decriminalized in 2020; Detroit followed in 2021; Hazel Park in 2021; Ferndale in 2021. Michigan has a more developed city-level decriminalization network than most states. Statewide ballot initiative efforts are ongoing.
Other Cities with Decriminalization
- Seattle, Washington — city resolution making plant medicines lowest enforcement priority, 2021
- Portland, Maine — decriminalized 2020
- Easthampton, Massachusetts — decriminalized 2021
- Arcata, California — decriminalized 2021
- Minneapolis, Minnesota — city resolution, 2021
States with Active Legislation in Progress (2026)
The following states have legislation in active consideration as of April 2026. "Active" means a bill has been introduced and is moving through committee — not simply that someone filed a bill that went nowhere.
Minnesota
SF 1203 — The Natural Medicine Health Act — passed committee hearings in 2025 and has support from the governor's office. If passed, it would create a licensed psilocybin services program modeled on Colorado's framework, including personal adult use provisions. Floor vote expected in 2026 session.
Hawaii
SB 738 would create a regulated psilocybin therapy program accessible through licensed clinical settings. Hawaii has been one of the most active legislatures on psychedelic research, passing resolutions supporting federal rescheduling and study funding. Clinical bill has bipartisan support.
Arizona
HB 2486 would establish a psilocybin research and therapy program through the state Department of Health. Arizona's passage of medical marijuana expansion and existing harm reduction infrastructure have created political conditions friendlier to psychedelic reform than most Western conservative states.
Vermont
H.72 would decriminalize personal possession of psilocybin and other psychedelics while establishing a working group to develop a licensed therapy framework. Vermont has passed drug decriminalization before and the political environment is favorable.
Nevada
SB 242 — establishing a psychedelic medicine working group and pilot program — passed in 2023. Rulemaking for a pilot program is ongoing in 2026. Nevada may have a limited licensed program operational in 2026–2027, primarily through existing health infrastructure.
States Where Psilocybin Remains Fully Illegal
The majority of US states have no decriminalization, no pending legislation with realistic passage prospects, and active enforcement of psilocybin possession laws. In these states, possession of psilocybin mushrooms is a criminal offense — typically a felony for amounts above personal use threshold.
Notable states where psilocybin remains fully illegal with no significant reform activity: Alabama, Arkansas, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Nebraska, North Dakota, South Carolina, South Dakota, Tennessee, Texas, Utah, West Virginia, Wisconsin, Wyoming.
See our state law pages for the specific penalties, statutes, and legal details for every US state and DC.
Federal Status
Psilocybin remains a Schedule I controlled substance under the federal Controlled Substances Act — meaning the federal government considers it to have no accepted medical use and high potential for abuse. This classification:
- Makes it illegal to manufacture, distribute, or possess psilocybin without a DEA Schedule I researcher registration
- Prevents VA and military facilities from prescribing psilocybin (research participation is different from prescribing)
- Restricts banking and financial services for state-licensed psilocybin businesses
- Creates complications for employers and federal contractors regarding drug testing
Rescheduling prospects in 2026: The DEA initiated a formal review of psilocybin scheduling following HHS recommendation, but the process is slow and the outcome uncertain. No rescheduling is expected in 2026. The most optimistic realistic timeline for federal rescheduling would be 2027–2028 if a new drug application is submitted and approved, triggering automatic rescheduling to a lower schedule.
What to Watch in the Rest of 2026
Massachusetts ballot measure (November 2026): The Natural Psychedelic Substances Act on the Massachusetts ballot is the highest-stakes psychedelic reform vote of 2026. Massachusetts is a large, influential state. Passage would add the fourth state with a licensed access framework and signal continued national momentum. Polling as of early 2026 shows majority support.
Minnesota legislative session: If the Natural Medicine Health Act passes the Minnesota legislature and is signed by the governor, it would be the first state to create a licensed program through the legislature (rather than voter ballot initiative) — a significant precedent.
New Mexico program launch: New Mexico completing its regulatory buildout and opening its first licensed service centers in late 2026 would be the third operational state program, further normalizing the model.
Federal research activity: The Trump executive order on veterans' psychedelic research is accelerating VA and DoD trial capacity. Whether additional clinical data from expanded trials meaningfully moves the federal rescheduling conversation is uncertain but worth watching.
How to Use This Information
If you want legal access now: Oregon and Colorado are your options. No residency required. See our Oregon Therapy Guide and Colorado Therapy Guide for full access information.
If you're in a decriminalized city or state: Personal use faces minimal enforcement risk, but there is no legal supply chain — obtaining psilocybin remains legally ambiguous at best. See Harm Reduction if you are using outside of a licensed program.
If you're in a state with pending legislation: Contacting your state legislators in support of pending bills matters — constituent contact has been cited by state legislators as meaningful input on these votes.
For state-by-state details: Every US state has its own page in our legal map covering current law, penalties, pending legislation, decriminalization status, and local advocacy contacts.